Diabetic Cardiomyopathy: an update of mechanisms contributing to this clinical entity
Inform treating therapists about your approach if comfortable
This article explores the relationship between GLP-1 medications and yeast infections, the physiological reasons behind these concerns, and how to distinguish between different types of metabolic treatments
[21] [5] Recurrent hypoglycaemia (low blood sugar), particularly if you are taking GLP-1 medications alongside other glucose-lowering drugs such as sulphonylureas or insulin
Food intake, particularly ingestion of carbohydrate-rich food, increases GLP-1 secretion, which promotes post-prandial insulin secretion, -cell proliferation, and glucose homeostasis, contributing to reducing glucose levels and aiding weight loss